gentian violet has been researched along with Tuberculosis, Drug-Resistant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akbal, AU; Birinci, A; Cayci, YT; Coban, AY; Durupinar, B; Uzun, M | 1 |
| Akbal, AU; Albay, A; Albayrak, N; Alp, A; Aslan, G; Bektore, B; Bicmen, C; Ceyhan, I; Coban, AY; Delialioğlu, N; Esen, N; Ozkutuk, A; Ozkutuk, N; Ozyurt, M; Selale, DS; Sig, AK; Surucuoglu, S; Ucarman, N; Uzun, M | 1 |
2 other study(ies) available for gentian violet and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
Evaluation of crystal violet decolorization assay for minimal inhibitory concentration detection of primary antituberculosis drugs against Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Biological Assay; Drug Resistance, Multiple, Bacterial; Ethambutol; Gentian Violet; Humans; Indicators and Reagents; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2016 |
Multicenter evaluation of crystal violet decolorization assay (CVDA) for rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis.
Topics: Calorimetry; Developed Countries; Gentian Violet; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis, Multidrug-Resistant | 2016 |